Integrated Filing — IndAS



General information about company

Scrip Code 532440
NSE Symbol MPSLTD
MSEI Symbol NOTLISTED
ISIN INE943D01017
Name of company MPS LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 12-11-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 04-11-2025
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 12-11-2025   08:30:00
End date and time of board meeting 12-11-2025   10:30:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 19,444.00 38,072.00
Other income 228.00 693.00
Total income 19,672.00 38,765.00
2 Expenses
(a) Cost of materials consumed 0.00 0.00
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 0.00 0.00
(d) Employee benefit expense 7,957.00 16,161.00
(e) Finance costs 29.00 57.00
(f) Depreciation, depletion and amortisation expense 610.00 1,311.00
(f) Other Expenses
1 Other Expenses 5,440.00 10,835.00
Total other expenses 5,440.00 10,835.00
Total expenses 14,036.00 28,364.00
3 Total profit before exceptional items and tax 5,636.00 10,401.00
4 Exceptional items 1,281.00 1,466.00
5 Total profit before tax 6,917.00 11,867.00
6 Tax expense
7 Current tax 1,512.00 2,891.00
8 Deferred tax (139.00) (92.00)
9 Total tax expenses 1,373.00 2,799.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 5,544.00 9,068.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 5,544.00 9,068.00
17 Other comprehensive income net of taxes 654.00 629.00
18 Total Comprehensive Income for the period 6,198.00 9,697.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 1,711.00 1,711.00
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 32.67 53.45
Diluted earnings (loss) per share from continuing operations 32.64 53.4
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 32.67 53.45
Diluted earnings (loss) per share from continuing and discontinued operations 32.64 53.4
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1.These results have been prepared in accordance with the recognition and measurement principles laid down in Ind AS notified under section 133 of the Companies Act 2013. These results have been reviewed by the Audit Committee and upon their recommendation approved by the Board of Directors at their meeting held on 12 November 2025. The Statutory auditors of the Company have carried out the limited review of the financial results for the quarter and half year ended 30 September 2025 and an unmodified review report has been issued. The same is available with Stock Exchanges and on the Company website. 2.The consolidated financial results of the Company its subsidiaries are prepared in accordance with Ind AS 110 Consolidated Financial Statements as specified under the Section 133 of the Companies Act 2013. 4.Subsequent to the quarter ended 30 September 2025 MPSi a material subsidiary of the Company has undertaken the following restructuring actions MPSi entered into a SSSHA on 10 October 2025 with Mr. Rodney Charles Beach an Australian resident and the Company. Pursuant to the terms of the SSSHA the Investor has agreed to invest INR 874 lacs through the preferential allotment of equity shares of MPSi. MPSi completed the 100% acquisition of the Liberate Group comprising Liberate Learning Pty Ltd AppeLearn Pty Ltd and Liberate eLearning Pty Ltd on 28 October 2025. Following completion the Liberate Group has become a wholly owned subsidiary of MPSi. Further Mr. Beach has assumed the role of President of Corporate learning segment. The process to exercise the balance 35% stake vide call option in Liberate group was initiated during the quarter ended 30 September 2025 in accordance with the valuation methodology set out in the transaction documents. Pursuant to this the liability of INR 1325 lacs and INR 1573 lacs respectively was written back under Exceptional Items net for the quarter and period ended 30 September 2025. Amount of INR 1573 lacs includes INR 248 lacs related to the said transaction shown under Other Income during quarter ended 30 June 2025. 5.Exceptional Items includes the restructuring cost of American Journal Experts business amounting to INR 107 lacs for the period ended 30 September 2025. 6. The Board of Directors in their meeting held on 16 May 2025 had recommended a final dividend of INR 50 per equity share face value of INR 10 per share for the financial year ended 2025. This was approved by the shareholders in the Annual General Meeting held on 29 August 2025 and was remitted to the shareholders by 06 September 2025. 7. The Board of Directors of MPS Limited approved a draft Scheme of Amalgamation on 18 July 2025 under Sections 230 and 232 of the Companies Act 2013 for the merger of ADI BPO Services Limited the Holding Company post demerger of its infrastructure management and investing business undertakings into MPS Limited. The Scheme is currently under review by the designated Stock Exchange for issuance of a NOC as per SEBI Listing Regulations. Filing with the NCLT will follow upon receipt of the NOC. 8.The standalone financial results of the Company are also available on the Company website. 9. The figures for the corresponding previous quarter or year have been regrouped or reclassified wherever necessary to make them comparable.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 30-09-2025
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 2,281.00
Capital work-in-progress 0.00
Investment property 90.00
Goodwill 24,932.00
Other intangible assets 7,853.00
Intangible assets under development 0.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 0.00
Trade receivables, non-current
Loans, non-current 0.00
Other non-current financial assets 240.00
Total non-current financial assets 240.00
Deferred tax assets (net) 3,141.00
Other non-current assets 311.00
Total non-current assets 38,848.00
2 Current assets
Inventories 0.00
Current financial asset
Current investments 3,041.00
Trade receivables, current 9,651.00
Cash and cash equivalents 6,420.00
Bank balance other than cash and cash equivalents 2,410.00
Loans, current 1.00
Other current financial assets 204.00
Total current financial assets 21,727.00
Current tax assets (net) 0.00
Other current assets 9,834.00
Total current assets 31,561.00
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 70,409.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,711.00
Other equity 47,299.00
Total equity attributable to owners of parent 49,010.00
Non controlling interest 0.00
Total equity 49,010.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities 679.00
Total non-current financial liabilities 679.00
Provisions, non-current 55.00
Deferred tax liabilities (net) 3,481.00
Deferred government grants, Non-current 0.00
Other non-current liabilities 0.00
Total non-current liabilities 4,215.00
Current liabilities
Current financial liabilities
Borrowings, current 0.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 105.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 3,020.00
Total Trade payable 3,125.00
Other current financial liabilities 2,180.00
Total current financial liabilities 5,305.00
Other current liabilities 10,315.00
Provisions, current 777.00
Current tax liabilities (Net) 787.00
Deferred government grants, Current 0.00
Total current liabilities 17,184.00
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 21,399.00
Total equity and liabilites 70,409.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2025 01-04-2025
Date of end of reporting period 30-09-2025 30-09-2025
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Research Solutions 11,958.00 22,842.00
2 Education Solutions 5,282.00 10,444.00
3 Corporate Learning 2,204.00 4,786.00
Total Segment Revenue 19,444.00 38,072.00
Less: Inter segment revenue
Revenue from operations 19,444.00 38,072.00
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Research Solutions 4,673.00 8,293.00
2 Education Solutions 2,139.00 3,903.00
3 Corporate Learning 141.00 390.00
Total Profit before tax 6,953.00 12,586.00
i. Finance cost 29.00 57.00
ii. Other Unallocable Expenditure net off Unallocable income 7.00 662.00
Profit before tax 6,917.00 11,867.00
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Research Solutions 0.00 0.00
2 Education Solutions 0.00 0.00
3 Corporate Learning 0.00 0.00
Total Segment Asset 0.00 0.00
Un-allocable Assets 0.00 0.00
Net Segment Asset 0.00 0.00
4 Segment Liabilities
Segment Liabilities
1 Research Solutions 0.00 0.00
2 Education Solutions 0.00 0.00
3 Corporate Learning 0.00 0.00
Total Segment Liabilities 0.00 0.00
Un-allocable Liabilities 0.00 0.00
Net Segment Liabilities 0.00 0.00
Disclosure of notes on segments Textual Information(2)



Text Block

Textual Information(2) 3a Based on the management approach as defined in Ind AS 108 Operating Segments the Chief Operating Decision Maker evaluates the Group performance and allocates resources based on an analysis of various performance indicators by business segments. The accounting principles used in the preparation of the financial results are consistently applied to record revenue and expenditure in individual segments. 3b Assets and liabilities used in the Group business are not identified to any of the reportable segments as these are used interchangeably between segments and the management believes that it is not practicable to provide segment disclosures relating to total assets and liabilities.



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2025 01-04-2025
B Date of end of reporting period 30-09-2025 30-09-2025
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Re-measurement of gain/(loss) on defined benefit plans 1000000 -8900000
Total Amount of items that will not be reclassified to profit and loss 10.00 (89.00)
2 Income tax relating to items that will not be reclassified to profit or loss 3.00 (22.00)
3 Amount of items that will be reclassified to profit and loss
1 Exchange differences on translation of foreign operations 64700000 69600000
Total Amount of items that will be reclassified to profit and loss 647.00 696.00
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 654.00 629.00



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 30-09-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 11,867.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 57.00
Adjustments for decrease (increase) in inventories 0.00
Adjustments for decrease (increase) in trade receivables, current 2,206.00
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (1,089.00)
Adjustments for decrease (increase) in other non-current assets 71.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current (38.00)
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 886.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (494.00)
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 1,311.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current (31.00)
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current (445.00)
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 219.00
Adjustments for dividend income 0.00
Adjustments for interest income 57.00
Adjustments for share-based payments 64.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow (212.00)
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items (1,601.00)
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 847.00
Net cash flows from (used in) operations 12,714.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 2,237.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 10,477.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 0.00
Purchase of property, plant and equipment 381.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 13.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 32.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 42.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (1,217.00)
Net cash flows from (used in) investing activities (1,601.00)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 0.00
Repayments of borrowings 0.00
Payments of lease liabilities 155.00
Dividends paid 8,642.00
Interest paid 57.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 47.00
Net cash flows from (used in) financing activities (8,807.00)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes 69.00
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 10.00
Net increase (decrease) in cash and cash equivalents 79.00
Cash and cash equivalents cash flow statement at beginning of period 6,341.00
Cash and cash equivalents cash flow statement at end of period 6,420.00